DNA Methylation Biomarkers for Cervical Cancer Screening

iStat Biomedical

Status: Unknown

Conditions: Cervical Intraepithelial Neoplasia; Cervical Cancer

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02605941

epigene-13151

Details and patient eligibility

About

The purpose of this prospective study is to evaluate whether DNA methylation can be applied in cervical cancer screening.

Enrollment: 5,000 estimated patients

Sex: Female

Ages: 20+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• women with age ≥20 and sexual experience
• Agree to sign ICF

Exclusion criteria

• women had received Hysterectomy
• women had destructive therapy for cervical lesions in 6 months, for examples: conization, Laser or cryotherapy, chemotherapy, and radiation therapy
• Women are at pregnancy or had baby delivery in 6 weeks